Earlier whole-genome sequencing revealed 7 distinct protein-altering mutations in JAK1 in HCC (accounting for 9.1%), of which five constitutively active mutants increased JAK1 kinase activity compared with WT JAK1 30. This evidence concerns the gene JAK1 and hepatocellular carcinoma.